valeant pharmaceuticals

U.S. stocks rose to close the day with moderate gains despite a larger than expected increase in jobless claims. “The end of 2015 Q1 is still my preferred liftoff date,” St. Louis Fed President Jim Bullard told The Wall Street Journal. The end of the first quarter is ahead of the...

U.S. stocks picked up where they left off after Thursday's sharp sell-off as positive earnings reports yet again took a backstage to geo-political uncertainties. Not helping the bull cause was nonfarm payrolls, rising by 209,000, less than the 233,000 expected. The jobless rate also ticked...

U.S. stocks posted steep losses as investors had plenty to worry about. Unable to reach a last-minute settlement, Argentina defaulted on its debt obligations. Naturally, as a global economy, the credit of one country affects other countries worldwide. The Labor Department reported that U.S....

U.S. stocks were lower as leaders from Britain, France, Germany and Canada have all made their respective countries position clear that Russia will face further sanctions if air investigators are not given full access to the crash site in Ukraine. Israel continued its ground offensive in the...

U.S. stocks rose as investors and traders digested comments from the Federal Reserve. The Federal Reserve Open Committee announced that it will further taper its asset purchases by another $10 billion. The Fed is now committing towards purchasing $35 billion of assets per month. The Fed also...

U.S. stocks were mostly unchanged on a catalyst-light day characterized by low volume. The SPDR S&P 500 ETF (NYSE: SPY) has a three-month daily average volume of over 101 million only traded hands 47.8 million times on Tuesday. With little economic or market moving catalysts due in the...

U.S. stocks ended a four day rally which saw the S&P 500 hit historical all-time highs. However, during Wednesday's trading session the ten-year Treasury yield traded as low as 2.439 percent, the lowest level seen since June 2013. Volume remained below average during Wednesday's trading...

U.S. stocks were little moved with the news-flow light, as would be expected prior to a long-weekend. In fact, Thursday's trading session proved to be the second lowest volume day of 2014. The S&P 500 closed above 1,900 and came within striking distance of matching its intraday all time...

U.S. stocks were mixed as the Dow finished in positive territory and the S&P 500 index turned negative after rising to within two points of its record close. The Nasdaq also turned negative towards the end of the day, declining for the third straight day. Earnings continue to come in mixed...

U.S. stocks fell after the S&P 500 and Nasdaq has risen for six consecutive trading sessions after new home sales data came in worse than expected. Investors could reasonably expect the markets to cool off after six straight days of gains especially as earnings continue to come in mixed....

U.S. stocks rose as investors cheered recent earning reports and a positive home sales data for March. A $45 billion M&A offer also contributed to Tuesday's buying action as investors could be excited and motivated to buy stocks ahead of a few rough weeks of bearish activity. The S&P...

Remember the days of youth when everybody wanted to hang out with you? To many friends, too little time was how your life worked as a high school and college student. Endo Pharmaceuticals (NASDAQ: ENDP) likely feels that way. Shares of this healthcare stock vaulted more than 10 percent in...